What are Kaiser's Mounjaro prior authorization criteria?

They commonly include a type 2 diabetes diagnosis, a recent A1C, proof of prior medication trials (such as metformin, an SGLT2 inhibitor, and semaglutide), no overlap with another GLP-1 drug, and region-specific steps. Kaiser Northwest's published criteria are a detailed example; your exact criteria depend on your plan.

Can my telehealth doctor submit a Kaiser Mounjaro prior authorization?

Not reliably. Kaiser's integrated model and participating-provider rules limit what an outside prescriber can do. An outside provider can help you access medication outside Kaiser, but usually cannot force a Kaiser approval.

What if Kaiser denies Mounjaro even though I have diabetes?

Read the denial reason. You're often missing one specific thing -- a current A1C, a required prior drug trial, a formulary exception, or continuation documentation. Fix that exact item rather than resubmitting the same request.

What if my A1C improved and Kaiser says I no longer qualify?

Ask your clinician whether continuation criteria apply, and make sure your baseline numbers and your response to treatment are documented, not just today's result.

Can I appeal a Kaiser Mounjaro denial?

Usually, yes -- you can appeal or request a formulary exception. The right path depends on your denial letter and plan. In California, you can also request an Independent Medical Review through the state Department of Managed Health Care after the plan's grievance process.

Is Zepbound a better request than Mounjaro for Kaiser weight-loss coverage?

It may be the cleaner FDA-approved weight-management path -- but only if your plan covers it and you meet its criteria. Ask your prescriber which approved use matches your diagnosis.

Where do I find my Kaiser formulary?

Start with kp.org/formulary, your region's formulary page, your Evidence of Coverage, and Member Services.

How much does Mounjaro cost without Kaiser coverage?

The list price is $1,112.16 per fill (four pens, a one-month supply). With commercial insurance and a type 2 diabetes prescription, eligible patients may pay as little as $25 a fill using the Lilly savings card; if a commercial plan does not cover Mounjaro, the card's other tier can be as low as $499 for a one-month fill. Medicare, Medicaid, TRICARE, and VA patients are not eligible for the savings card.

What if I can't get Mounjaro through Kaiser at all?

Your options may include appealing, requesting an exception, switching to a different FDA-approved GLP-1 that matches your diagnosis, using a manufacturer cash program, or considering a non-Kaiser provider.

Last verified: June 10, 2026The RX Index Editorial TeamIndependent guide — not affiliated with Kaiser PermanenteDisclosure

Kaiser Mounjaro Prior Authorization: 2026 Criteria, Document Checklist, and What to Do If You’re Denied

There is no single Kaiser rule — there’s a stack of regional rules that nobody puts in one place. We did. Find your bucket, get the exact documents, and stop getting denied on a paperwork gap.

Disclosure: The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We are not affiliated with Kaiser Permanente. Some links may be affiliate links, which never change the coverage facts on this page. This guide is general information, not medical advice.

Short version: Kaiser Mounjaro prior authorization means your Kaiser doctor has to prove — on paper, before the pharmacy will fill it — that you match Kaiser’s coverage rules. For most people, Kaiser treats Mounjaro as a type 2 diabetes medication. Approval usually comes down to three things: your diagnosis, your recent lab numbers, and proof you’ve already tried certain other diabetes medicines first. Weight-loss-only requests are restricted on most Kaiser plans.

Which situation are you in? Start here.

Find your row. It tells you the fast answer and your single best next move.

Your situation	The fast answer	Your best next step
You have type 2 diabetes	Kaiser may cover Mounjaro if your plan's diabetes criteria are met	Gather your latest A1C, your diagnosis note, and your past medication list
You want it for weight loss only	Don't assume Mounjaro is the right request -- it may not be	Ask if your plan covers weight-loss drugs at all, and whether Zepbound is the correct path
You already take it and you're switching to Kaiser	Switching does not automatically keep your coverage	Build a "continuation" file: old approval, fill history, current labs
Kaiser says "try Ozempic first"	That's likely a real step-therapy rule, not a brush-off	Ask exactly which step is missing, then document it
Kaiser denied it	Do not resubmit the same thing unchanged	Read the denial reason and fix the one thing that's missing

Use this page if…

Kaiser or your pharmacy said Mounjaro "needs prior authorization"
You're switching to Kaiser and you already take Mounjaro
Kaiser denied Mounjaro and you don't understand why
Your Kaiser doctor said you may need to "try Ozempic first"
You want to know what it costs if Kaiser says no

This isn’t the right page if…

You just want a coupon (jump to the cost section)
You need urgent medical advice -- call your doctor
You're looking for dosing instructions -- talk to your prescriber

Get my Kaiser Mounjaro PA checklist → free, no email

The frustrating truth: there is no single Kaiser Mounjaro rule

We can’t promise Kaiser will approve you, and neither can any honest page. Kaiser is regional. A rule in Oregon isn’t the rule in Georgia. A large-employer plan isn’t a Medi-Cal plan. Your neighbor’s approval doesn’t mean yours.

Most pages answer “Does Kaiser cover Mounjaro?” with a shrug — “it varies.” True, but useless. What you can control is the paperwork. Kaiser prior-authorization reviews are criteria-based: your doctor’s submission has to match the boxes Kaiser is checking. Miss one box, and the request can die on paperwork. Match the boxes, and at least the reviewer is judging your actual case.

Does Kaiser require prior authorization for Mounjaro?

In most Kaiser plans, yes — Mounjaro requires prior authorization and usually comes with a quantity limit too. Prior authorization is simply approval your prescriber must get before the medicine is covered. “On the formulary” does not mean “approved for you” — it means the drug is on the list but locked behind rules you have to meet.

Definitions: the words Kaiser and the pharmacy use

Term	What it means
Prior authorization (PA)	Your doctor sends Kaiser proof you meet coverage rules before Kaiser pays
Formulary	Your plan's list of covered drugs -- listed drugs can still be restricted
Quantity limit (QL)	A cap on how much you can get in a set time
Step therapy	A required order: you may have to try preferred drugs first before Kaiser covers Mounjaro
Formulary exception	A request to cover a drug that isn't normally covered, when your doctor shows it's medically necessary

The five things Kaiser is almost always checking

Your diagnosis

Mounjaro is reviewed as a diabetes drug on most plans

Your region and plan

Your specific formulary and benefit design set the rules

Your recent numbers

A current A1C or, for weight programs, your BMI

What you've already tried

Past medications, and whether they failed, caused side effects, or weren't safe

The right pathway and prescriber

The correct form, the correct diagnosis pathway, and a Kaiser or participating prescriber

What are the Kaiser Mounjaro prior authorization rules by region?

Kaiser Mounjaro rules are not one national rule — they differ by region, plan, and benefit. The pattern across everything we checked: diabetes is the stronger path, weight-loss-only is restricted or excluded, and quantity limits are common. But the specifics are yours to confirm.

Kaiser region / situation	What public Kaiser documents show	What you still need to verify
Northwest (Oregon / SW Washington)	Kaiser Northwest's published tirzepatide (Mounjaro) criteria, revised 02/12/26, lay out a detailed diabetes step-therapy ladder, apply quantity limits, and cover Mounjaro for weight loss only if your plan includes a weight-loss drug benefit (otherwise member cash price applies).	Whether your specific Northwest plan includes a weight-loss medication benefit.
All regions -- weight loss only	In an October 2024 announcement, Kaiser said starting January 2025, weight-loss medications -- including GLP-1s -- would no longer be covered for weight loss alone, but continue to be covered when prescribed as part of a disease-management program for conditions such as diabetes.	Your plan's exact weight-loss benefit and the criteria attached to it.
Medi-Cal (California Medicaid)	Effective January 1, 2026, Medi-Cal no longer covers GLP-1 drugs for weight loss only; previously approved PAs ended December 31, 2025. Mounjaro continues to be covered for type 2 diabetes if your prescriber submits a diagnosis code. Members under 21 may still get weight-loss coverage through an approved PA under federal EPSDT rules.	That your prescriber submits the diabetes diagnosis code; your age for EPSDT eligibility.
Other regions and plans (California commercial, Colorado, Georgia, Hawaii, Mid-Atlantic, Washington commercial, Medicare)	Coverage, drug tier, and restrictions vary by plan and are updated monthly. A drug listed on the formulary can still carry PA, quantity limits, or an exclusion.	Look up Mounjaro on kp.org/formulary, read your Evidence of Coverage, or call Member Services at the number on your card.

Does Kaiser cover Mounjaro if you have type 2 diabetes?

A type 2 diabetes diagnosis makes Mounjaro coverage much more likely with Kaiser, but it doesn’t guarantee it. Plans commonly require a recent A1C, proof you’ve tried preferred diabetes medicines first, and no overlap with another GLP-1 drug. Mounjaro is FDA-approved as an add-on to diet and exercise to improve blood sugar control in adults and children 10 and older with type 2 diabetes.

Why your A1C and lab numbers matter

Kaiser often wants a recent A1C on file to show your diabetes isn’t controlled well enough on what you’re taking now. If your last lab is old, that’s a gap. Get a current one before the PA goes in. (This is documentation guidance — your doctor decides what’s right for you.)

Why your past medications matter (step therapy)

This is the big one. Many Kaiser plans want to see that you’ve already tried — and not done well on, or couldn’t tolerate, or shouldn’t take — certain preferred diabetes drugs before Mounjaro. Kaiser Northwest’s published criteria are a clear example. For an adult starting Mounjaro for type 2 diabetes, those criteria look for:

Metformin at the maximum tolerated dose (or a reason you can't take it)
A sulfonylurea (or a reason you can't take it)
Pioglitazone (or a reason you can't take it)
An SGLT2 inhibitor such as Jardiance (or a reason you can't take it)
A real trial of semaglutide (the medicine in Ozempic) and/or liraglutide that didn't get your A1C under control
An A1C or GMI still above goal (their criteria use specific thresholds)

Source: Kaiser Permanente Northwest Region, Criteria for Drug Coverage -- tirzepatide (Mounjaro), revised 02/12/26. Step-therapy lists differ by region — confirm yours.

The trap: “I have diabetes” may not be enough on its own. If your chart doesn’t show those prior tries — or the reason you can’t take them — that’s a denial waiting to happen.

The trap nobody warns you about: “my A1C improved”

If Mounjaro is working and your A1C drops into a healthy range, great for your health — but renewal and new-member reviews can hinge on whether the chart still shows why treatment is needed. Make sure your doctor documents your baseline numbers and your response to treatment, not just today’s snapshot. Don’t let good results get presented as missing context.

Does Kaiser cover Mounjaro for weight loss?

Be careful here: do not assume Kaiser will process a weight-loss request under Mounjaro. Mounjaro is FDA-approved only for type 2 diabetes. Most Kaiser plans stopped covering weight-loss drugs for weight loss alone in 2025, so a weight-loss request often routes to a Zepbound pathway, an exception request, or a flat no.

This section can save you weeks. People search “Kaiser Mounjaro for weight loss,” get denied, and never understand it was the wrong request the whole time.

Mounjaro vs. Zepbound: the difference that decides your whole case

Brand	Active ingredient	FDA approval	Kaiser coverage lane
Mounjaro	Tirzepatide	Type 2 diabetes	Diabetes pathway -- step therapy usually required
Zepbound	Tirzepatide	Chronic weight management; moderate-to-severe obstructive sleep apnea	Weight-management pathway -- separate criteria, benefit must exist

Same medicine, very different paperwork. And even before criteria, there’s a yes/no gate: does your plan even cover medications for weight loss? Per Kaiser’s October 2024 announcement, weight-loss drugs stopped being covered for weight loss alone starting January 2025. If your plan has no weight-loss drug benefit, a prior authorization usually can’t beat that — it’s an exclusion, not a hurdle.

Exactly what to ask Kaiser Member Services (word for word)

"Does my plan cover medications used to treat weight loss?"
"Is Mounjaro on my formulary, and for which diagnosis?"
"Is Zepbound covered under my plan's weight-management benefit?"
"Is prior authorization, step therapy, or a quantity limit required?"
"Where can my prescriber find the exact coverage criteria?"

Write the answers down with the date and the rep’s name.

Denied for weight loss and want an FDA-approved cash option?

An outside provider like Ro cannot help you use Kaiser coverage — if Kaiser benefits are your priority, stay in-system and work the appeal below. But if Kaiser has told you no for weight loss and you want a clear, FDA-approved path you pay for directly, Ro offers Zepbound (the FDA-approved tirzepatide for weight management), Wegovy, and Ozempic. Ro lists Zepbound KwikPen at $299 for the first month, then $399–$449/month after that; membership is $39 first month, then as low as $74/month, billed separately. Verify current pricing before relying on it.

Check FDA-approved options outside Kaiser with Ro →

Sponsored. Not a Kaiser approval or workaround. For Zepbound/Wegovy weight-loss path only. Verify pricing.

Will Kaiser make me try Ozempic before Mounjaro?

Sometimes, yes — trying semaglutide (the medicine in Ozempic) first can be a documented step in Kaiser’s Mounjaro criteria. It means your doctor has to show you tried it and it didn’t work, you couldn’t tolerate it, or you can’t safely take it. The fix is to find the exact missing step — not to argue that Mounjaro is simply “better.”

What actually counts as a “failed trial”

Insurers don’t accept “I tried it for a week and didn’t like it.” Kaiser Northwest defines an “adequate trial” as a 3-month treatment duration, and says intolerance does not include mild, expected side effects that resolve with continued treatment. So the two things that satisfy a step-therapy rule are:

Genuine trial that didn’t reach goalYour doctor documents the dose, the time period (at least 3 months), and the result.

Intolerance or contraindicationA real side effect that made you stop, or a medical reason you shouldn’t take it at all.

The one message that beats arguing

“Can you tell me which specific criterion Kaiser says is missing — diagnosis, current A1C, a prior trial of metformin / an SGLT2 inhibitor / semaglutide, an intolerance note, or a formulary exception? I want the PA or appeal to address that exact reason instead of resubmitting the same request.”

What should your doctor submit for Kaiser Mounjaro prior authorization?

The strongest Kaiser Mounjaro PA is not a prescription — it’s a packet. A prescription alone says “I want this.” A complete packet says “I meet your rules.” Those are very different things to a reviewer.

Your Kaiser Mounjaro PA document checklist

Privacy note: Don’t post private medical details into any online tool. Use this checklist to gather what you bring to your Kaiser clinician.

Document	Why it matters	Where to find it	Kaiser-backed?
Kaiser region + plan name	Criteria change by region and benefit	Member card, member portal, Evidence of Coverage	Confirmed (rules differ by region/plan)
Diagnosis / diagnosis code	Mounjaro is usually a diabetes-pathway request	After-visit summary, chart diagnosis	Confirmed (NW criteria; Medi-Cal rule)
Recent A1C (or GMI)	Many criteria require current blood-sugar proof	Lab results, CGM report	Confirmed (NW criteria use A1C/GMI thresholds)
Medication history	Step therapy depends on prior tries	Kaiser pharmacy history, outside pharmacy records	Confirmed (NW step-therapy ladder)
Intolerance / contraindication notes	Needed when you can't take a required step drug	Chart note, allergy/reaction record	Confirmed (NW criteria allow intolerance/contraindication)
Current medication list	Helps rule out overlap with another GLP-1	Kaiser med list	General PA best practice
BMI / current weight	Needed for weight-management criteria	Visit notes, vitals	Confirmed (NW weight-management criteria)
Prior approval + fill history	Critical if you're continuing or switching	Pharmacy records, old insurer letters	General PA best practice
The denial letter (if any)	Tells you exactly what to fix	Kaiser message center, mail, pharmacy	General PA best practice

Where do you find the Kaiser Mounjaro prior authorization form?

There is no single national Kaiser Mounjaro PA form — it depends on your region and plan. The safest move is to let your Kaiser prescriber pull the correct, current form for your plan. Don’t download a random Kaiser form from another region and assume it applies to you — the criteria and even the drug’s pathway can differ.

Copy-and-send: your Kaiser secure message

“Hi — I’d like to request Mounjaro and want to make sure the prior authorization is complete the first time. Could you please confirm my diagnosis on file, attach my most recent A1C, and document my prior medication trials (and any intolerances) so the submission matches Kaiser’s coverage criteria? If a different pathway or form fits my situation better, please let me know. Thank you.”

Get the editable checklist for my exact situation →

Diabetes, weight management, continuation, or denial — find yours

What can you do if Kaiser denies Mounjaro?

Don’t appeal blindly, and don’t resubmit the same request. Find the exact denial reason first, then fix that one thing. A denial feels like a wall. It’s usually a door with a specific lock.

The Kaiser Mounjaro denial decoder

If your denial says…	It usually means…	What to gather next
No type 2 diabetes diagnosis	Your request didn't match the diabetes pathway	Diagnosis notes; ask if the Zepbound/weight pathway fits instead
Weight-loss drugs not covered	A plan exclusion -- a PA may not beat it	Your Evidence of Coverage; ask about alternatives or cash options
Must try Ozempic / semaglutide first	Step therapy	Proof you tried it, or an intolerance/contraindication note
Missing or old A1C	A documentation gap	An updated A1C or CGM/GMI report
A1C no longer qualifies	A continuation-rule snag	Baseline A1C, your response over time, your doctor's rationale
Non-formulary	Not on your list, or needs an exception	A formulary exception request + medical-necessity note
Outside-prescriber issue	Kaiser may need its own prescriber to own it	Ask your Kaiser PCP or endocrinologist to submit
Duplicate GLP-1 therapy	You can't overlap two of these drugs	Current med list and a plan to stop the other one
Refill / dose-change rejection	A quantity-limit or renewal problem	Prior approval dates, dose history, the pharmacy claim details

Appeal vs. resubmit vs. exception — what’s the difference?

Fix and resubmitThe reason was a simple gap (old lab, missing note). Patch it, send it back.

Formulary exceptionThe drug isn't covered for you, but your doctor can argue medical necessity.

Formal appealYou disagree with the decision itself. This is where you escalate.

California members: you have a strong appeal right

If you’re in California and Kaiser denies, changes, or delays a requested medical service, you can apply for an Independent Medical Review (IMR) through the state’s Department of Managed Health Care (DMHC) — an outside review by doctors who don’t work for Kaiser. DMHC says that if the review overturns the denial, your health plan is required to authorize the requested service. Start at dmhc.ca.gov. Other states have their own external-review routes — ask Kaiser for your appeal rights in writing.

Decode my denial reason → get my exact next step

What if you’re switching to Kaiser and already take Mounjaro?

Switching to Kaiser does not automatically keep your Mounjaro coverage — treat the move as a documentation project. Members who plan this before their old coverage ends avoid the scariest gap: a lapse in their medication.

Your continuation-of-care file

✓Current dose and the date you started

✓The diagnosis it was prescribed for

✓Baseline A1C/GMI and current A1C/GMI

✓Baseline and current weight (if weight-related)

✓Pharmacy fill history (proof you've been on it)

✓Prior PA approval letters from your old insurer

✓Any side-effect history

✓Prior medication trials

One detail worth knowing: Kaiser Northwest requires that members continuing tirzepatide for weight management have documented at least 5% weight loss since starting it. If you’re switching and you’re on it for weight, your results and your dates matter — bring them.

Your timeline before old coverage ends

30 days out:Download your labs and pharmacy claims. Ask your current doctor for a treatment summary.

Two weeks out:Schedule your first Kaiser visit early -- don't wait until you're out of medicine.

Before the switch:Ask Member Services about Mounjaro's formulary status and PA rules on your new plan, and refill if appropriate and allowed.

Can an outside telehealth provider get Kaiser to approve Mounjaro?

Not reliably. Kaiser is an integrated system. An outside telehealth company can help you access FDA-approved GLP-1 medication outside Kaiser, but it generally cannot force a Kaiser prior authorization or get a Kaiser plan to pay for an outside prescription. A prescription written by an outside service usually won’t be covered by your Kaiser plan — which means you’d pay cash for it anyway.

An outside route might fit if you:

Got denied by Kaiser and want an FDA-approved option you pay for yourself
Want a predictable cash price instead of fighting a PA
Are between plans or shopping coverage and want to see your options

It’s the wrong move if you:

Are trying to force Kaiser to approve a PA (it can’t)
Have a Kaiser plan that requires Kaiser’s own prescriber and pharmacy
Need in-network Kaiser endocrinology notes to support coverage

If you’ve been denied for weight loss and want an FDA-approved cash option

For weight loss, the FDA-approved brand is Zepbound (tirzepatide), not Mounjaro. We won’t push you toward “compounded tirzepatide” as a cheaper stand-in — compounded products are not FDA-approved Mounjaro or Zepbound, and we’re not going to blur that line to make a sale.

Denied for weight loss? Check FDA-approved options outside Kaiser.

Ro offers a free GLP-1 Insurance Coverage Checker plus an insurance concierge that handles PA paperwork for the meds it supports — currently Zepbound, Wegovy, and Ozempic. Ro Body membership is $39 for the first month, then as low as $74/month with annual prepay; medication billed separately. FEHB members can use the concierge; Medicaid and most government plans aren’t eligible for the insurance route, though some can use cash-pay options. This is not a Kaiser workaround and does not guarantee Kaiser approval.

Check FDA-approved GLP-1 options outside Kaiser with Ro →

Sponsored. Not a Kaiser approval or workaround. For Zepbound/Wegovy weight-loss path only.

How much does Mounjaro cost if Kaiser won’t approve it?

Without coverage, Mounjaro’s list price is $1,112.16 per fill (four pens, a one-month supply, up from $1,069.08 on January 1, 2026). Most people don’t pay that. If you have commercial (non-government) insurance and a type 2 diabetes prescription, Eli Lilly’s Mounjaro Savings Card can bring eligible patients to as little as $25 a fill. The card expires December 31, 2026.

Your situation	What you pay	The fine print
Commercial insurance that covers Mounjaro (T2D PA approved)	As little as $25 per fill	Max savings $150/month, up to $1,950/year; up to 13 fills; 18+, U.S. resident, T2D prescription
Commercial insurance that does NOT cover Mounjaro	As low as $499 for a one-month fill	Up to $8,411/year; same eligibility rules
No commercial insurance (uninsured)	Closer to the $1,112.16 list price	Lilly Cares (income-based assistance) may help; check lilly.com
Medicare, Medicaid, TRICARE, VA, or government coverage	Not eligible for the Mounjaro Savings Card	Federal rules exclude government plans; no workaround

Coupon warning: The savings card requires an FDA-approved use — meaning type 2 diabetes for Mounjaro. If your prescription is for off-label weight loss, the Mounjaro card won’t apply. Always confirm current terms on Lilly’s site the day you enroll.

See the full Mounjaro savings card guide →

What’s the fastest path for your exact situation?

The fastest route depends on your bucket. Don’t try to do everything at once; do the next right thing.

Your bucket	Best next action
Type 2 diabetes, new request	Gather your A1C and prior-medication records, then message your doctor
Weight-loss request	Confirm whether your plan covers weight-loss drugs and whether Zepbound is the right pathway
Already on it, switching to Kaiser	Build your continuation file before your old coverage ends
Denied	Decode the exact reason, then fix that one thing
Refill / dose rejected	Ask if it's a quantity-limit, refill-too-soon, or renewal issue
Outside-Kaiser backup needed	Compare FDA-approved options you pay for directly

Safety and eligibility issues that can affect approval

FDA boxed warning: Mounjaro carries a warning about thyroid C-cell tumors seen in animal studies. It is contraindicated for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and for serious allergic reactions to tirzepatide. Your prescriber decides whether Mounjaro is safe for you.

This page helps you organize coverage documents. It does not decide your treatment. If you have questions about whether Mounjaro is safe for you, that’s a conversation for a licensed clinician.

How we verified this Kaiser Mounjaro prior authorization guide

We reviewed public Kaiser formularies and prior-authorization criteria, FDA prescribing information for Mounjaro and Zepbound, Eli Lilly’s pricing and savings resources, the Medi-Cal Rx GLP-1 notice, and California’s IMR process. This page does not guarantee coverage. Your Kaiser region, your specific plan, your Evidence of Coverage, your diagnosis, and your prescriber’s documentation control the final decision.

What we verified	Primary source
Mounjaro FDA approval (T2D; adults and children 10+); boxed warning; contraindications	FDA/Lilly Mounjaro Prescribing Information
Zepbound FDA approval (chronic weight management; obstructive sleep apnea)	FDA/Lilly Zepbound Prescribing Information
Northwest step-therapy ladder (metformin, sulfonylurea, pioglitazone, SGLT2, semaglutide); 3-month adequate-trial definition; A1C/GMI thresholds; quantity limits	Kaiser NW Criteria for Drug Coverage -- tirzepatide (Mounjaro), revised 02/12/26
Weight-loss drugs no longer covered for weight loss alone starting January 2025	Kaiser Permanente coverage announcement, October 2024
Medi-Cal dropped weight-loss-only GLP-1 coverage effective January 1, 2026; Mounjaro continues for T2D with diagnosis code; EPSDT rule for under-21	Medi-Cal Rx 'Changes to GLP-1 Drug Coverage -- Effective January 1, 2026'
Mounjaro list price ($1,112.16/fill); savings-card tiers ($25 covered / $499 not covered); government exclusions; expiration 12/31/2026	Eli Lilly pricing and Mounjaro Savings Card terms
California IMR process; DMHC requirement to authorize if review overturns denial	California DMHC, dmhc.ca.gov

What we could not verify for you: Kaiser updates formularies monthly, and we could not confirm every employer-specific plan, every Medicare Advantage or Medicaid variation, or any private member-portal result. Always check your exact coverage through your Evidence of Coverage, kp.org/formulary, or Kaiser Member Services.
Last verified: June 10, 2026. Next scheduled review: September 2026.

Frequently asked questions about Kaiser Mounjaro prior authorization

Most Kaiser Mounjaro questions come down to one of four things: your diagnosis, your benefit, step therapy, or your documentation.

Does Kaiser cover Mounjaro?: Sometimes -- it depends on your Kaiser region, plan, diagnosis, and whether you meet the prior-authorization criteria. Coverage is more likely for type 2 diabetes than for weight loss, and it is rarely automatic.
Does Kaiser require prior authorization for Mounjaro?: In most Kaiser plans, yes. Mounjaro is commonly listed with a prior-authorization requirement and a quantity limit, meaning your doctor must show you meet the rules before it is covered. It is not universal, so confirm your plan.
What are Kaiser's Mounjaro prior authorization criteria?: They commonly include a type 2 diabetes diagnosis, a recent A1C, proof of prior medication trials (such as metformin, an SGLT2 inhibitor, and semaglutide), no overlap with another GLP-1 drug, and region-specific steps. Kaiser Northwest's published criteria are a detailed example; your exact criteria depend on your plan.
Does Kaiser cover Mounjaro for weight loss?: Do not assume so. Mounjaro is FDA-approved only for type 2 diabetes; the FDA-approved tirzepatide for weight management is Zepbound. Per Kaiser's October 2024 announcement, weight-loss drugs stopped being covered for weight loss alone starting January 2025, though they remain covered as part of a disease-management program for conditions like diabetes.
Will Kaiser make me try Ozempic before Mounjaro?: On some plans, yes. Trying semaglutide (the medicine in Ozempic) first can be a documented step, and Kaiser Northwest's diabetes criteria look for it. Ask which specific step-therapy rule applies to your plan, then have your doctor document the trial, intolerance, or contraindication.
Can my telehealth doctor submit a Kaiser Mounjaro prior authorization?: Not reliably. Kaiser's integrated model and participating-provider rules limit what an outside prescriber can do. An outside provider can help you access medication outside Kaiser, but usually cannot force a Kaiser approval.
What if Kaiser denies Mounjaro even though I have diabetes?: Read the denial reason. You're often missing one specific thing -- a current A1C, a required prior drug trial, a formulary exception, or continuation documentation. Fix that exact item rather than resubmitting the same request.
What if my A1C improved and Kaiser says I no longer qualify?: Ask your clinician whether continuation criteria apply, and make sure your baseline numbers and your response to treatment are documented, not just today's result.
Can I appeal a Kaiser Mounjaro denial?: Usually, yes -- you can appeal or request a formulary exception. The right path depends on your denial letter and plan. In California, you can also request an Independent Medical Review through the state Department of Managed Health Care after the plan's grievance process.
Is Zepbound a better request than Mounjaro for Kaiser weight-loss coverage?: It may be the cleaner FDA-approved weight-management path -- but only if your plan covers it and you meet its criteria. Ask your prescriber which approved use matches your diagnosis.
Where do I find my Kaiser formulary?: Start with kp.org/formulary, your region's formulary page, your Evidence of Coverage, and Member Services.
How much does Mounjaro cost without Kaiser coverage?: The list price is $1,112.16 per fill (four pens, a one-month supply). With commercial insurance and a type 2 diabetes prescription, eligible patients may pay as little as $25 a fill using the Lilly savings card; if a commercial plan does not cover Mounjaro, the card's other tier can be as low as $499 for a one-month fill. Medicare, Medicaid, TRICARE, and VA patients are not eligible for the savings card.
What if I can't get Mounjaro through Kaiser at all?: Your options may include appealing, requesting an exception, switching to a different FDA-approved GLP-1 that matches your diagnosis, using a manufacturer cash program, or considering a non-Kaiser provider.

Still not sure which path is yours?

You don’t have to figure this out alone. Take our free 60-second matching quiz. Answer a few quick questions and we’ll point you to the path that fits your insurance, your diagnosis, and your situation — Kaiser appeal, FDA-approved cash option, or something else.

Get my free GLP-1 action plan → 60 seconds Denied for weight loss? Check Zepbound/Wegovy options with Ro →

Sponsored. Not a Kaiser workaround. For weight-loss path only.

Related guides

By The RX Index Editorial Team. The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This guide is general information, not medical advice, and does not guarantee coverage. Verify your benefits with your plan; any treatment decisions require a licensed clinician. We are not affiliated with Kaiser Permanente. Last verified: June 10, 2026.

Primary sources

FDA/Lilly -- Mounjaro (tirzepatide) Prescribing Information (type 2 diabetes indication; boxed warning; contraindications)
FDA/Lilly -- Zepbound (tirzepatide) Prescribing Information (chronic weight management; obstructive sleep apnea)
Kaiser Permanente Northwest Region -- Criteria for Drug Coverage: tirzepatide (Mounjaro), revised 02/12/26
Kaiser Permanente -- Weight-loss medication coverage announcement (October 2024)
Medi-Cal Rx -- 'Changes to GLP-1 Drug Coverage -- Effective January 1, 2026'
Eli Lilly -- Mounjaro pricing and Savings Card terms (pricinginfo.lilly.com; mounjaro.lilly.com/savings-resources)
California Department of Managed Health Care -- Independent Medical Review process (dmhc.ca.gov)
Ro -- GLP-1 Insurance Coverage Checker and weight-loss program pages

Related guides